Structure Therapeutics Statistics
Total Valuation
GPCR has a market cap or net worth of $1.91 billion. The enterprise value is $1.00 billion.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GPCR has 57.20 million shares outstanding. The number of shares has increased by 91.97% in one year.
Current Share Class | n/a |
Shares Outstanding | 57.20M |
Shares Change (YoY) | +91.97% |
Shares Change (QoQ) | +15.78% |
Owned by Insiders (%) | 3.03% |
Owned by Institutions (%) | 132.05% |
Float | 51.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.13 |
P/TBV Ratio | 2.13 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 27.63, with a Debt / Equity ratio of 0.00.
Current Ratio | 27.63 |
Quick Ratio | 27.38 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.29% and return on invested capital (ROIC) is -16.18%.
Return on Equity (ROE) | -20.29% |
Return on Assets (ROA) | -15.46% |
Return on Capital (ROIC) | -16.18% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.19M |
Employee Count | 93 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -138,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.91% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -34.91% |
50-Day Moving Average | 38.79 |
200-Day Moving Average | 39.72 |
Relative Strength Index (RSI) | 41.58 |
Average Volume (20 Days) | 836,169 |
Short Selling Information
Short Interest | 10.44M |
Short Previous Month | 10.80M |
Short % of Shares Out | 18.26% |
Short % of Float | 20.41% |
Short Ratio (days to cover) | 15.69 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -142.16M |
Pretax Income | -100.26M |
Net Income | -110.55M |
EBITDA | -141.34M |
EBIT | -142.16M |
Earnings Per Share (EPS) | -$2.22 |
Full Income Statement Balance Sheet
The company has $915.29 million in cash and $4.39 million in debt, giving a net cash position of $910.90 million or $15.93 per share.
Cash & Cash Equivalents | 915.29M |
Total Debt | 4.39M |
Net Cash | 910.90M |
Net Cash Per Share | $15.93 |
Equity (Book Value) | 896.80M |
Book Value Per Share | 15.66 |
Working Capital | 890.22M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$101.90 million and capital expenditures -$2.43 million, giving a free cash flow of -$104.33 million.
Operating Cash Flow | -101.90M |
Capital Expenditures | -2.43M |
Free Cash Flow | -104.33M |
FCF Per Share | -$1.82 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |